Report cover image

MediBeacon Inc - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Feb 16, 2026
Length 34 Pages
SKU # GBDT20881320

Description

Summary

Medibeacon Inc (Medibeacon), a subsidiary of Innovate Corp, is a medical technology company. The company offers pipeline products such as real time kidney function monitoring solutions. It offers the renal function system that helps clinicians with the continuous monitoring of the kidney. Medibeacon also provides pipeline a portfolio of the light activated agents and preclinical applications for transdermal renal function measurement continuously. The company provides measured GFR for preclinical studies. It serves medical schools, academic centers, research institutes, and pharmaceutical companies. Medibeacon is headquartered in Saint Louis, Missouri, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MediBeacon Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

34 Pages
MediBeacon Inc Company Overview
MediBeacon Inc Company Snapshot
MediBeacon Inc Pipeline Products and Ongoing Clinical Trials Overview
MediBeacon Inc – Pipeline Analysis Overview
MediBeacon Inc - Key Facts
MediBeacon Inc - Major Products and Services
MediBeacon Inc Pipeline Products by Development Stage
MediBeacon Inc Ongoing Clinical Trials by Trial Status
MediBeacon Inc Pipeline Products Overview
MB-102
MB-102 Product Overview
MB-102 Clinical Trial
MB-112
MB-112 Product Overview
MB-202
MB-202 Product Overview
MB-212
MB-212 Product Overview
MB-301
MB-301 Product Overview
MB-404
MB-404 Product Overview
MediBeacon Inc - Key Competitors
MediBeacon Inc - Key Employees
MediBeacon Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
MediBeacon Inc, Recent Developments
Oct 30, 2025: MediBeacon to Present at the Upcoming American Society of Nephrology (ASN) Kidney Week 2025
Oct 21, 2025: MediBeacon Receives Regulatory Approval to Sell Transdermal GFR System in China
Oct 21, 2025: Medibeacon Receives Regulatory Approval to Sell the Transdermal Gfr System in China
Feb 25, 2025: MediBeacon Transdermal GFR System Receives Device Approval in China
Jan 30, 2025: MediBeacon Receives PMA Approval for Transdermal GFR Monitor
Jan 20, 2025: FDA approves MediBeacon's TGFR system for kidney function assessment
Nov 16, 2022: MediBeacon receives $10 million in amended agreements with Huadong Medicine to accelerate development of transdermal GFR measurement system
Oct 22, 2018: FDA grants breakthrough device status for MediBeacon''s Transdermal GFR Measurement System
May 06, 2017: MediBeacon presents gastrointestinal permeability research
Mar 02, 2017: MediBeacon Completes Successful Clinical Study of Transdermal Glomerular Filtration Rate Monitor on Impaired Kidney Function Subjects
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
MediBeacon Inc Pipeline Products and Ongoing Clinical Trials Overview
MediBeacon Inc Pipeline Products by Equipment Type
MediBeacon Inc Pipeline Products by Indication
MediBeacon Inc Ongoing Clinical Trials by Trial Status
MediBeacon Inc, Key Facts
MediBeacon Inc, Major Products and Services
MediBeacon Inc Number of Pipeline Products by Development Stage
MediBeacon Inc Pipeline Products Summary by Development Stage
MediBeacon Inc Ongoing Clinical Trials by Trial Status
MediBeacon Inc Ongoing Clinical Trials Summary
MB-102 - Product Status
MB-102 - Product Description
MB-102 - A Pilot Study to Assess the Feasibility and Safety of MB-102 in Ocular Angiography As Compared to Fluorescein Sodium
MB-102 - An Open Label, Single Center Study to Evaluate the Effect of Protein Loading on the Measurement of Renal Reserve Using the MediBeacon Transdermal GFR System
MB-102 - An Open Label, Single-Center, Safety and Pharmacokinetic Study of Lumitrace Injection (Relmapirazin) and the Use of the MediBeacon Transdermal GFR System Using the TGFR Reusable Sensor With TGFR Disposable Ring for the Evaluation of Kidney Function in Patients With Heart Failure
MB-112 - Product Status
MB-112 - Product Description
MB-202 - Product Status
MB-202 - Product Description
MB-212 - Product Status
MB-212 - Product Description
MB-301 - Product Status
MB-301 - Product Description
MB-404 - Product Status
MB-404 - Product Description
MediBeacon Inc, Key Employees
MediBeacon Inc, Subsidiaries
Glossary
List of Figures
MediBeacon Inc Pipeline Products by Equipment Type
MediBeacon Inc Pipeline Products by Development Stage
MediBeacon Inc Ongoing Clinical Trials by Trial Status

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.